DYANAVEL XR, Quillivant XR, and QuilliChew ER have a substantial opportunity for abuse and misuse and should cause compound use challenges, which include dependancy. Continue to keep these medicines in a secure location to avoid abuse and misuse. Offering or giving freely these medicines may harm Ot